Physician profile
Timothy Viator
NPI 1659369916
$514.83
in general payments reported to CMS, 2019-2025
16 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.17 · 2020: $111 · 2021: $34.78 · 2022: $26.76 · 2023: $71.11 · 2024: $80.51 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $57.80 | 2019-2021 | |
| Astellas Pharma US INC | $52.76 | 2023-2024 | Veozah |
| Abbvie INC. | $50.15 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.61 | 2020 | |
| Sumitomo Pharma America, INC. | $46.97 | 2024-2025 | Myfembree |
| Millicent US INC | $40.07 | 2025 | Femlyv, Intrarosa |
| Exeltis, USA INC. | $31.74 | 2023-2025 | Slynd |
| Novo Nordisk INC | $28.05 | 2025 | Ozempic, Rybelsus |
| Allergan, INC. | $27.47 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $25.29 | 2020 | |
| Kyowa Kirin, INC. | $24.55 | 2025 | |
| Becton, Dickinson and Company | $23.77 | 2023 | Venclose Maven Catheter |
| Lilly USA, LLC | $19.43 | 2025 | Zepbound, Mounjaro |
| Pfizer INC. | $15.85 | 2024 | |
| Shire North American Group INC | $11.78 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $11.54 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Viator listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.